The Zhitong Finance App learned that Peger Biopharmaceutical-B (02565.HK) rose more than 10% at the end of the session. As of press release, it rose 8.16% to HK$3.645, with a turnover of HK$116 million.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.